A Win For Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc. (ETON:NASDAQ) shot up at $8.56, representing a gain of 13.1%. On Wed, Apr 14, 2021, ETON:NASDAQ hit a New 2-Week High of $7.57. The stock got featured on our News Catalysts scanner on Wed, Mar 17, 2021 at 05:20 PM in the 'INVESTOR UPDATE' category. From Wed, Mar 31, 2021, the stock recorded 55.56% Up Days and 60.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Eton Pharmaceuticals, Inc. (ETON:NASDAQ)
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products utilizing the FDA's 505(b)(2) regulatory pathway, to fulfill an unmet patient need. It has a diversified pipeline of around eight product candidates in various stages of development.
Top 10 Gainers:
- Trevena, Inc. (TRVN:NASDAQ), 31.58%
- Wilhelmina International, Inc. (WHLM:NASDAQ), 29.81%
- KSPN (KSPN:NASDAQ), 19.44%
- PLBY (PLBY:NASDAQ), 15.83%
- CompX International Inc. (CIX:NYSEMKT), 14.38%
- EEIQ (EEIQ:NASDAQ), 14.19%
- Ballantyne Strong, Inc (BTN:NYSEMKT), 13.83%
- Eton Pharmaceuticals, Inc. (ETON:NASDAQ), 13.08%
- Weingarten Realty Investors (WRI:NYSE), 12.55%
- Kingstone Companies, Inc. (KINS:NASDAQ), 11.53%